Загрузка...
Role of Immunotherapy for Renal Cell Cancer in 2011
High-dose interleukin-2 (HD IL-2) and interferon were the most commonly administered therapies before the recent introduction of targeted agents, including vascular endothelial growth factor and mammalian target of rapamycin pathway inhibitors. Although the new agents result in a progression-free su...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4020430/ https://ncbi.nlm.nih.gov/pubmed/21917625 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|